245 related articles for article (PubMed ID: 27803007)
1. Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.
Stauder R; Eichhorst B; Hamaker ME; Kaplanov K; Morrison VA; Österborg A; Poddubnaya I; Woyach JA; Shanafelt T; Smolej L; Ysebaert L; Goede V
Ann Oncol; 2017 Feb; 28(2):218-227. PubMed ID: 27803007
[TBL] [Abstract][Full Text] [Related]
2. Management of unfit elderly patients with chronic lymphocytic leukemia.
Eichhorst B; Hallek M; Goede V
Eur J Intern Med; 2018 Dec; 58():7-13. PubMed ID: 30527922
[TBL] [Abstract][Full Text] [Related]
3. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
[TBL] [Abstract][Full Text] [Related]
4. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.
Droz JP; Albrand G; Gillessen S; Hughes S; Mottet N; Oudard S; Payne H; Puts M; Zulian G; Balducci L; Aapro M
Eur Urol; 2017 Oct; 72(4):521-531. PubMed ID: 28089304
[TBL] [Abstract][Full Text] [Related]
5. Management of elderly and unfit patients with chronic lymphocytic leukemia.
Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R
Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157
[TBL] [Abstract][Full Text] [Related]
6. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
Pinilla-Ibarz J; Emole J
Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
[TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.
Morrison VA; Hamlin P; Soubeyran P; Stauder R; Wadhwa P; Aapro M; Lichtman S
J Geriatr Oncol; 2015 Mar; 6(2):141-52. PubMed ID: 25491101
[TBL] [Abstract][Full Text] [Related]
8. Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach.
Balducci L; Dolan D
Cancer Control; 2015 Oct; 22(4 Suppl):3-6. PubMed ID: 26618340
[TBL] [Abstract][Full Text] [Related]
9. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.
Zelenetz AD; Gordon LI; Wierda WG; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Byrd JC; Czuczman MS; Fayad LE; Fisher RI; Glenn MJ; Habermann TM; Harris NL; Hoppe RT; Horwitz SM; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Nademanee A; Porcu P; Press O; Rabinovitch R; Reddy N; Reid E; Saad AA; Sokol L; Swinnen LJ; Tsien C; Vose JM; Wilson L; Yahalom J; Zafar N; Dwyer M; Sundar H;
J Natl Compr Canc Netw; 2015 Mar; 13(3):326-62. PubMed ID: 25736010
[TBL] [Abstract][Full Text] [Related]
11. Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
Turcsanyi P; Kriegova E; Kudelka M; Radvansky M; Kruzova L; Urbanova R; Schneiderova P; Urbankova H; Papajik T
Leuk Res; 2019 Apr; 79():60-68. PubMed ID: 30852300
[TBL] [Abstract][Full Text] [Related]
12. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
Voorhies BN; Stephens DM
Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993
[TBL] [Abstract][Full Text] [Related]
13. Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapies.
Ysebaert L; Feugier P; Michallet AS
Curr Opin Oncol; 2015 Sep; 27(5):365-70. PubMed ID: 26154708
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group.
Goede V; Bahlo J; Chataline V; Eichhorst B; Dürig J; Stilgenbauer S; Kolb G; Honecker F; Wedding U; Hallek M
Leuk Lymphoma; 2016; 57(4):789-96. PubMed ID: 26377031
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.
Buccheri V; Barreto WG; Fogliatto LM; Capra M; Marchiani M; Rocha V
Ann Hematol; 2018 Dec; 97(12):2269-2278. PubMed ID: 30315344
[TBL] [Abstract][Full Text] [Related]
16. Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia.
Zent CS; Kay NE
Curr Oncol Rep; 2004 Sep; 6(5):348-54. PubMed ID: 15291975
[TBL] [Abstract][Full Text] [Related]
17. Prognostic markers and standard management of chronic lymphocytic leukemia.
Stilgenbauer S
Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
[TBL] [Abstract][Full Text] [Related]
18. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia.
Cramer P; Hallek M; Eichhorst B
Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
Tees MT; Flinn IW
Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic lymphocytic leukemia.
Stilgenbauer S; Furman RR; Zent CS
Am Soc Clin Oncol Educ Book; 2015; ():164-75. PubMed ID: 25993154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]